Great earnings have these stocks firing

💔And saying goodbye to a faithful friend                                                                                                                                                                                                                                                                                                                                                                                                                 August 09, 2024 | [Read Online]( *sponsored by The [Market Master’s Trading Room]( is open today but will be a little quiet, as we mourn the loss of JW’s stock market faithful companion, Bentley. Although Bentley could not “legally” tell someone to buy or sell a stock, a bark or two from him when JW was digging in it gave you all the confirmation you needed.  Fly high, Bentley – little buddy, loyal sidekick and intuitive stock market wizard. You will be missed! FOCUS LIST🔎 RKLB - Up over 12% in the pre-market after reporting better than expected earnings, record revenue BW - Up over 20% in pre after reporting better than expected earnings IOVA- Up over 20% in pre after reporting better than expected earnings, strong guidance *sponsored by FINANCEBUZZ Hands Down Some of the Best Credit Cards for Balance Transfers Did you know some credit cards can actually help you get out of debt faster? Yes, it sounds crazy. But it’s true. The secret: Find a card with a “0% intro APR" period for balance transfers. Then, transfer your debt balance and pay it down as much as possible during the intro period. No interest means you could pay off the debt faster. [Check out the full list of cards you can use to do this here.]( HOTLIST🔥 RKLB - Up over 12% in the pre-market after reporting better than expected earnings, record revenue Rocket Lab USA, Inc. (RKLB) a space company that provides launch services and space systems solutions for the space and defense industries. In the after-hours yesterday the [company reported]( Q2 2024 financial results. Highlights include: Achieved highest revenue quarter in Company history at $106 million. Successful Electron launches for NASA, commercial constellation operators Synspective, Kineis, and the Korea Advanced Institute of Science and Technology (KAIST). Electron remains the most frequently launched small rocket globally and Electron launches have accounted for 64% of all non-SpaceX orbital U.S. launches in 2024 to date. For the third quarter of 2024, Rocket Lab expects: Revenue between $100 million and $105 million. Space Systems revenue between $79 million and $84 million. Launch Services revenue of approximately $21 million. Adjusted EBITDA loss of $31 million to $33 million. Basic Shares Outstanding of 498 million. The stock traded up over 12% in the pre-market in reaction to the positive financial results. The first target for bulls is the pre-market high at $5.71. Beyond that, $6, $6.60, $7 and $7.50 come into play. Below $5.71, targets to the downside are $5.50, $5.20, $5 and then a gap fill at $4.77. BW - Up over 20% in pre after reporting better than expected earnings Babcock & Wilcox Enterprises, Inc. (BW) together with its subsidiaries, provides energy and emissions control solutions to industrial, electrical utility, municipal, and other customers worldwide. In the after-hours yesterday, the [company reported]( Q2 2024 financial results. Highlights include: Revenue of $233.6 million, Net Income of $25.4 million, and Operating Income of $42.2 million, which exceeded expectations Adjusted EBITDA of $23.3 million, $24.6 million excluding BrightLoopTM and ClimateBrightTM expenses, ahead of expectations Reiterate Full Year 2024 Adjusted EBITDA target range of $105.0 million to $115.0 million, excluding BrightLoop and ClimateBright expenses Improved balance sheet and liquidity through sale of B&W's Denmark renewable service subsidiary for net cash proceeds of $83.5 million Announced backlog of $472.4 million and implied backlog of $757.8 million in project opportunities Announced total YTD bookings of $383.1 million and implied bookings of $668.5 million, a 71% increase compared to the first half of 2023 Achieved annualized cost savings of approximately $25.0 million to date related to strategic business realignment progressing toward stated target of over $30.0 million The stock traded up over 20% in the pre-market in reaction to the results. The $1.31 area acted as support in the pre-market and will be an important level to watch. Above it, targets to the upside are $1.40, $1.50, $1.60, $1.65 and then the after-hours high at $1.70. Beyond that, $1.80, $2 and $2.20 come into play. Below $1.31, targets to the downside are $1.28, $1.20 and then a gap fill at $1.11.  New to Options Trading? How does trading ONE Stock, Every Day sound? Dip your toe in with JW and his crew in Market Navigator! $79 MONTHLY OFFER NOW OPEN [(share this link with a friend if you’re already a pro!)]( IOVA- Up over 20% in pre after reporting better than expected earnings, strong guidance Iovance Biotherapeutics Inc. (IOVA) is a commercial-stage biotechnology company that develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. In the after-hours yesterday, the [company reported]( Q2 and half year 2024 results. Highlights include: Strong Momentum Continues for Amtagvi™ (Lifileucel) U.S. Launch with $31.1 Million in Total 2Q24 Revenue Total Product Revenue Guidance of $53-$55 Million for 3Q24, $160-$165 Million for FY24, and $450-$475 Million for FY25 Cash Position: As of July 24, 2024, Iovance had cash, cash equivalents, investments, and restricted cash of $449.6 million, compared to $346.3 million at December 31, 2023. The current cash position and anticipated product revenue are expected to be sufficient to fund current and planned operations, including manufacturing expansion, into early 2026. The stock traded up over 20% in the pre-market in reaction to the positive results. The first target to the upside is prior resistance at $10.42 with the pre-market high at $10.97. Beyond that $12, $13 and $14 come into play. Below $10.42, targets to the downside are $9.60, $8.80, $8.40 and then a gap fill at $7.94. MARKET NEWS 📰 P.S. Make sure you text “RAGE” to (888) 404-5747 to get all of our latest HOT STOCK ideas! Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. *Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 2024 360 WallStreet 62 Calef Hwy. #233 lee, NH 03861, United States of America [Terms of Service](